Bioconjugate Chemistry · 2011 · 91 citations · 21 references
PharmacyPharmaceuticsPharmacologyCancer PharmacologyDrug DeliveryMolecular OncologyCancer Drug DeliveryCell-penetrating Delivery SystemsCell-penetrating PeptidesCellular Drug UptakePeptide DeliveryTransport Across Biological MembranesCationic PeptidesCell-penetrating PolymersDrug-delivery ApplicationsPeptide Delivery SystemsPeptide-mediated DeliveryPh DependencePh-dependent PermeationTumor-targeting Peptides
TP10-5 (TK) was screened as the most promising candidate among the designed analogues of transportan 10 (TP10), a cell penetrating peptide (CPP) with remarkable capacity for membrane translocation. However, low levels of specificity and high toxicity limit its successful use for drug delivery applications. Here, we developed a new type of acid-activated CPP (TH) by replacement of all lysines of TK with histidines. As expected, histidine-containing TH can be activated and subsequently enter cells at pH 6.0, whereas it is less active at pH 7.4. In contrast, the uptake of TK has no significant difference for both pH values. Importantly, the toxicity of TH is significantly lower than that of TK under physiological conditions. After attachment of camptothecin (CPT) to TH, this conjugate exhibited remarkable cytotoxicity to cancer cells in a pH-dependent manner compared with free CPT and TK-CPT. This study opens a new avenue to design CPPs that preferentially enter cells in acidic solid tumors, with minimal cellular uptake in normal tissues.
21
Acid pH in tumors and its potential for therapeutic exploitation.
Ian F. Tannock, Daniela Rotin · PubMed · 1989 · 1.6K citations
Medicine, Oncology, Pharmacology +16
Quyen T. Nguyen, Emilia S. Olson, Todd A. Aguilera et al. · Proceedings of the National Academy of Sciences · 2010 · 473 citations · Full text